Liver damage from stress and aging might be reversible reveals study
HQ Team July 19, 2024: Researchers at Duke University have gained some new insights into age-related degeneration of liver. In an animal experiment,
HQ Team July 19, 2024: A new pill that treats hormone sensitive advance prostate cancer has been approved by the National Institute for
HQ Team July 18, 2024: Researchers at the Virginia Commonwealth University’s School of Medicine and the Richmond VA Medical Center say that almost
Conduct disorder is a result of extensive changes in the structure of the brain and is most noticeable in the cerebral cortex, or
HQ Team July 18, 2024: In a reversal strategy in the war against cancer, researchers are now aiming to genetically cloak healthy cells
Japanese researchers have developed a non-invasive alternative to detect human papillomavirus by testing urine samples, a discovery that may transform cervical cancer screening.
British-Swedish AstraZeneca has acquired Amolyt Pharma for $1.05 billion to gain access to Lyon, France-based company’s rare disease, late-stage pipeline.
Climate change is making days longer by a few milliseconds as the ice melts in Antarctica and Greenland is causing a shift in
HQ Team July 16, 2024: A new animal study has found a new therapy that is able to boost inuslin-producing cells by 700%